悼念德巴希-丹达(Debashish Danda)教授,医学学士、医学博士、医学博士、FRCP。

IF 2.4 4区 医学 Q2 RHEUMATOLOGY International Journal of Rheumatic Diseases Pub Date : 2024-10-28 DOI:10.1111/1756-185X.15380
Masayoshi Harigai, Nighat Ahmad, Alakendu Ghosh, Syed Atiqul Haq, Xinping Tian
{"title":"悼念德巴希-丹达(Debashish Danda)教授,医学学士、医学博士、医学博士、FRCP。","authors":"Masayoshi Harigai,&nbsp;Nighat Ahmad,&nbsp;Alakendu Ghosh,&nbsp;Syed Atiqul Haq,&nbsp;Xinping Tian","doi":"10.1111/1756-185X.15380","DOIUrl":null,"url":null,"abstract":"<p>We are deeply saddened by the untimely passing away of Professor Debashish Danda, a towering figure in the field of rheumatology, who tragically lost his life in a road accident on 24 February 2024. His sudden departure has left an irreplaceable void in the hearts of his colleagues, students, and the global rheumatology community.</p><p>Professor Danda's illustrious career was marked by his unwavering dedication to advancing rheumatology in India and the Asia-Pacific region and across the globe. His journey began with his graduation from the Jawaharlal Institute of Postgraduate Medical Education &amp; Research, Puducherry, in 1985. He furthered his education with an MD in internal medicine from G.S.V.M. Medical College, Kanpur, in 1990 and a post-doctoral degree in clinical immunology from the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, in 1995.</p><p>After advanced training in rheumatology in Adelaide, Australia, Professor Danda returned to India, where he joined the Christian Medical College (CMC), Vellore. There, he single-handedly established the Department of Clinical Immunology and Rheumatology, which has since grown to be one of the largest patient cohorts in the world. His vision led to the developing of a robust postgraduate education system at CMC, including the initiation of DM training in rheumatology and clinical immunology and a PhD program. His influence can be seen in the many faculty members at CMC who were his protégés.</p><p>Professor Danda's leadership extended beyond national borders. He served as President of the Indian Rheumatology Association (IRA) from 2017 to 2019. He held numerous roles within the Asia-Pacific League of Associations for Rheumatology (APLAR), including Editor-in-Chief of the International Journal of Rheumatic Diseases (IJRD), Treasurer, Vice President, and ultimately, President from 2021 to 2023. His dedication to rheumatology was recognized internationally, earning him numerous awards, including the Distinguished International Rheumatology Professional Award from the American College of Rheumatology (ACR) in 2023 (Figure 1-A).</p><p>A prolific author, Professor Danda published over 200 papers and delivered lectures at prestigious conferences worldwide. His research, particularly in the field of vasculitis, was not just significant, but truly groundbreaking. He led the APLAR Vasculitis Special Interest Group as Convener, advancing the diagnosis, education, and research of vasculitis, especially Takayasu arteritis, in the Asia-Pacific region (Figure 1-B). His establishment of the APLAR Academy and the Rheumatology Course for Physicians reflects his passion for education and his commitment to reducing disparities in rheumatology care.</p><p>Professor Danda was a brilliant scientist, visionary leader, and compassionate human being. He fought tirelessly against disparities in healthcare, ensuring that zonal and gender inequities were addressed within APLAR. His commitment to his patients and colleagues was unwavering, and his influence will be felt for generations.</p><p>The loss of Professor Danda is a monumental blow to the rheumatology community worldwide. His contributions to the field are not just significant, but truly irreplaceable, and his memory will forever inspire those who knew him. We extend our deepest condolences to his beloved family, Dr. Sumita Danda, MD, DM, and his son, Asheerwad Danda, during this difficult time.</p><p>MH and XT concieved the manuscript, MH and SAH drafted it, and all authors critically reviewed and approved it.</p><p>The authors declare no conflict of interest.</p>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"27 11","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1756-185X.15380","citationCount":"0","resultStr":"{\"title\":\"In memoriam: Professor Debashish Danda, MBBS, MD, DM, FRCP\",\"authors\":\"Masayoshi Harigai,&nbsp;Nighat Ahmad,&nbsp;Alakendu Ghosh,&nbsp;Syed Atiqul Haq,&nbsp;Xinping Tian\",\"doi\":\"10.1111/1756-185X.15380\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We are deeply saddened by the untimely passing away of Professor Debashish Danda, a towering figure in the field of rheumatology, who tragically lost his life in a road accident on 24 February 2024. His sudden departure has left an irreplaceable void in the hearts of his colleagues, students, and the global rheumatology community.</p><p>Professor Danda's illustrious career was marked by his unwavering dedication to advancing rheumatology in India and the Asia-Pacific region and across the globe. His journey began with his graduation from the Jawaharlal Institute of Postgraduate Medical Education &amp; Research, Puducherry, in 1985. He furthered his education with an MD in internal medicine from G.S.V.M. Medical College, Kanpur, in 1990 and a post-doctoral degree in clinical immunology from the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, in 1995.</p><p>After advanced training in rheumatology in Adelaide, Australia, Professor Danda returned to India, where he joined the Christian Medical College (CMC), Vellore. There, he single-handedly established the Department of Clinical Immunology and Rheumatology, which has since grown to be one of the largest patient cohorts in the world. His vision led to the developing of a robust postgraduate education system at CMC, including the initiation of DM training in rheumatology and clinical immunology and a PhD program. His influence can be seen in the many faculty members at CMC who were his protégés.</p><p>Professor Danda's leadership extended beyond national borders. He served as President of the Indian Rheumatology Association (IRA) from 2017 to 2019. He held numerous roles within the Asia-Pacific League of Associations for Rheumatology (APLAR), including Editor-in-Chief of the International Journal of Rheumatic Diseases (IJRD), Treasurer, Vice President, and ultimately, President from 2021 to 2023. His dedication to rheumatology was recognized internationally, earning him numerous awards, including the Distinguished International Rheumatology Professional Award from the American College of Rheumatology (ACR) in 2023 (Figure 1-A).</p><p>A prolific author, Professor Danda published over 200 papers and delivered lectures at prestigious conferences worldwide. His research, particularly in the field of vasculitis, was not just significant, but truly groundbreaking. He led the APLAR Vasculitis Special Interest Group as Convener, advancing the diagnosis, education, and research of vasculitis, especially Takayasu arteritis, in the Asia-Pacific region (Figure 1-B). His establishment of the APLAR Academy and the Rheumatology Course for Physicians reflects his passion for education and his commitment to reducing disparities in rheumatology care.</p><p>Professor Danda was a brilliant scientist, visionary leader, and compassionate human being. He fought tirelessly against disparities in healthcare, ensuring that zonal and gender inequities were addressed within APLAR. His commitment to his patients and colleagues was unwavering, and his influence will be felt for generations.</p><p>The loss of Professor Danda is a monumental blow to the rheumatology community worldwide. His contributions to the field are not just significant, but truly irreplaceable, and his memory will forever inspire those who knew him. We extend our deepest condolences to his beloved family, Dr. Sumita Danda, MD, DM, and his son, Asheerwad Danda, during this difficult time.</p><p>MH and XT concieved the manuscript, MH and SAH drafted it, and all authors critically reviewed and approved it.</p><p>The authors declare no conflict of interest.</p>\",\"PeriodicalId\":14330,\"journal\":{\"name\":\"International Journal of Rheumatic Diseases\",\"volume\":\"27 11\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1756-185X.15380\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Rheumatic Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15380\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15380","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

德巴希-丹达(Debashish Danda)教授是风湿病学领域的杰出人物,他于2024年2月24日在一场交通事故中不幸去世,我们对此深感悲痛。他的突然离去在他的同事、学生和全球风湿病学界心中留下了不可替代的空白。丹达教授辉煌职业生涯的标志是,他坚定不移地致力于推动印度、亚太地区乃至全球风湿病学的发展。1985 年,丹达教授从普度切里贾瓦哈拉尔研究生医学教育与研究学院(Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry)毕业。1990 年,他获得坎普尔 G.S.V.M. 医学院内科医学博士学位,1995 年获得勒克瑙桑贾伊-甘地医学科学研究生院临床免疫学博士后学位。在澳大利亚阿德莱德接受风湿病学高级培训后,丹达教授返回印度,加入韦洛尔基督教医学院(CMC)。在那里,他一手创建了临床免疫学和风湿病学系,该系现已发展成为世界上最大的患者群体之一。他的远见卓识促使 CMC 建立了强大的研究生教育体系,包括启动风湿病学和临床免疫学的 DM 培训和博士生项目。Danda 教授的领导力超越了国界。2017 年至 2019 年,他担任印度风湿病学协会(IRA)主席。他在亚太风湿病学协会联盟(APLAR)中担任过许多职务,包括《国际风湿病杂志》(IJRD)主编、财务主管、副主席,并最终于2021年至2023年担任主席。他对风湿病学的奉献得到了国际认可,获得了众多奖项,包括 2023 年美国风湿病学会(ACR)颁发的杰出国际风湿病学专业人士奖(图 1-A)。他的研究,尤其是在脉管炎领域的研究,不仅意义重大,而且具有真正的开创性。他以召集人的身份领导了亚太实验室协会脉管炎特别兴趣小组,推动了亚太地区脉管炎(尤其是高安动脉炎)的诊断、教育和研究(图 1-B)。丹达教授是一位杰出的科学家、有远见的领导者和富有同情心的人。他坚持不懈地与医疗保健中的不平等作斗争,确保在亚太地区风湿病研究院内解决地区和性别不平等问题。他对病人和同事的承诺坚定不移,他的影响将代代相传。他对这一领域的贡献不仅意义重大,而且确实无可替代,对他的怀念将永远激励着那些认识他的人。在这个艰难的时刻,我们向他挚爱的家人、医学博士苏米塔-丹达博士(Dr. Sumita Danda, MD, DM)和他的儿子阿谢尔瓦德-丹达(Asheerwad Danda)表示最深切的慰问。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
In memoriam: Professor Debashish Danda, MBBS, MD, DM, FRCP

We are deeply saddened by the untimely passing away of Professor Debashish Danda, a towering figure in the field of rheumatology, who tragically lost his life in a road accident on 24 February 2024. His sudden departure has left an irreplaceable void in the hearts of his colleagues, students, and the global rheumatology community.

Professor Danda's illustrious career was marked by his unwavering dedication to advancing rheumatology in India and the Asia-Pacific region and across the globe. His journey began with his graduation from the Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, in 1985. He furthered his education with an MD in internal medicine from G.S.V.M. Medical College, Kanpur, in 1990 and a post-doctoral degree in clinical immunology from the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, in 1995.

After advanced training in rheumatology in Adelaide, Australia, Professor Danda returned to India, where he joined the Christian Medical College (CMC), Vellore. There, he single-handedly established the Department of Clinical Immunology and Rheumatology, which has since grown to be one of the largest patient cohorts in the world. His vision led to the developing of a robust postgraduate education system at CMC, including the initiation of DM training in rheumatology and clinical immunology and a PhD program. His influence can be seen in the many faculty members at CMC who were his protégés.

Professor Danda's leadership extended beyond national borders. He served as President of the Indian Rheumatology Association (IRA) from 2017 to 2019. He held numerous roles within the Asia-Pacific League of Associations for Rheumatology (APLAR), including Editor-in-Chief of the International Journal of Rheumatic Diseases (IJRD), Treasurer, Vice President, and ultimately, President from 2021 to 2023. His dedication to rheumatology was recognized internationally, earning him numerous awards, including the Distinguished International Rheumatology Professional Award from the American College of Rheumatology (ACR) in 2023 (Figure 1-A).

A prolific author, Professor Danda published over 200 papers and delivered lectures at prestigious conferences worldwide. His research, particularly in the field of vasculitis, was not just significant, but truly groundbreaking. He led the APLAR Vasculitis Special Interest Group as Convener, advancing the diagnosis, education, and research of vasculitis, especially Takayasu arteritis, in the Asia-Pacific region (Figure 1-B). His establishment of the APLAR Academy and the Rheumatology Course for Physicians reflects his passion for education and his commitment to reducing disparities in rheumatology care.

Professor Danda was a brilliant scientist, visionary leader, and compassionate human being. He fought tirelessly against disparities in healthcare, ensuring that zonal and gender inequities were addressed within APLAR. His commitment to his patients and colleagues was unwavering, and his influence will be felt for generations.

The loss of Professor Danda is a monumental blow to the rheumatology community worldwide. His contributions to the field are not just significant, but truly irreplaceable, and his memory will forever inspire those who knew him. We extend our deepest condolences to his beloved family, Dr. Sumita Danda, MD, DM, and his son, Asheerwad Danda, during this difficult time.

MH and XT concieved the manuscript, MH and SAH drafted it, and all authors critically reviewed and approved it.

The authors declare no conflict of interest.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
4.00%
发文量
362
审稿时长
1 months
期刊介绍: The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.
期刊最新文献
Massive Gastrointestinal Bleeding in Patient With Immunoglobulin (Ig) A Vasculitis Patient due to Widespread Arterial Microaneurysms Treated With Intravenous Immunoglobulin (IVIG) Seroconversion of Rheumatoid Factor Prior to the Onset of Rheumatoid Arthritis in Patients With Interstitial Lung Disease: A Single-Center Retrospective Case Series The TabNet Model for Diagnosing Axial Spondyloarthritis Using MRI Imaging Findings and Clinical Risk Factors Vasculitic Myopathy as an Early Manifestation of ANCA-Associated Vasculitis: The Necessity of Its Differentiation From Polymyalgia Rheumatica The Utility of Thermography in Detecting Subclinical Joint Inflammation at the Elbows in Patients With Rheumatoid Arthritis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1